FeesSafety
Pluang+

IBM selects four organizations for AI-driven education and workforce development grants

Market News
10 Nov 2026, 14:00 WIB
PRNewsWire
View Source
Bullish
IBM selects four organizations for AI-driven education and workforce development grants

IBM announced four organizations chosen for its 2026 Impact Accelerator cohort, providing technology and expertise grants to support AI and digital skills development in education and workforce systems. Projects include developing AI literacy tools for educators, advancing AI and quantum readiness in Colorado, combating job posting bias in Latin America, and expanding career opportunity platforms in India. These initiatives aim to help communities adapt to AI-driven labor market changes and emerging tech fields. IBM will support these projects through co-design, development, and implementation phases, backed by $75 million in committed resources through 2028.

IBM's 2026 Impact Accelerator program supporting AI and quantum learning initiatives provides context for technology sector trends. For readers following Technology stocks, here is Pluang's market snapshot as of Nov 10, 2026 18:12 WIB: out of 150 priced US Technology stocks, 51 rose and 89 fell. Notable movers include ZETA at USD 31.54 with a -2.71% change and a typical hold time of 21 days, PUBM at USD 18.56 down 2.47% with 100% sell order activity, and AXTI at USD 41.93 down 2.28% with a 57% sell order activity.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
46 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
46 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
46 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
46 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App